AMDL launches five cancer tests:
This article was originally published in Clinica
AMDL is negotiating international distribution deals for five cancer tests: CEA for colorectal cancer; PSA for prostate cancer; total beta-human chorionic gonadotropin for testicular cancer; and AFP and ferritin tests for liver cancer. AMDL expects the companies which license the ELISAs to obtain regulatory approval for the kits. The names of the interested parties have not been disclosed.